This week’s CotW includes the landscape of biomarkers and clinical trials for Alzheimer’s disease.  There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials.
Gray: Disease
Blue: Biomarkers
Purple: Clinical Trials
Yellow: FDA Cleared and Approved Tests

AlzGraph.png